Baidu
map

我国急性冠心病年轻化趋势明显

2015-01-26 刘军, 赵冬, 刘静等.2006至2012年急性冠状动脉综合 中国循环杂志

我国急性冠心病年轻化趋势明显:6年两次调查发病年龄下降3岁 我们经常说,中国的冠心病年轻化趋势明显,但怎么体现呢?北京安贞医院刘军和赵冬等的一项发现,2006年中国急性冠脉综合征患者平均年龄是64.7岁,而2012年平均年龄则降低至61.9岁,平均降低了3岁左右。 2006年中青年(≤60岁)的比例占32.1%,2012年则占到了42.5%。增加了32.4%。男性的年轻化

我国急性冠心病年轻化趋势明显:6年两次调查发病年龄下降3岁

我们经常说,中国的冠心病年轻化趋势明显,但怎么体现呢?北京安贞医院刘军和赵冬等的一项发现,2006年中国急性冠脉综合征患者平均年龄是64.7岁,而2012年平均年龄则降低至61.9岁,平均降低了3岁左右。

2006年中青年(≤60岁)的比例占32.1%,2012年则占到了42.5%。增加了32.4%。男性的年轻化更明显,2012年男性患者年龄<55岁为36.1%,比2006年的28.7%增加了25.8%。

研究还发现,2012年ACS 患者伴有高血压、高胆固醇血症、糖尿病的比例较2006年均显著增加,尤其是伴有高胆固醇血症的患者,较6年前增加了2.1倍。

当然,急性冠状动脉综合征的临床诊治水平也在提高。比如,使用经皮冠脉介入治疗(PCI)和循证医学证实有效的二级预防药物的使用率也有所提高,尤其是氯吡格雷和他汀类药物的使用。

2012年β受体阻滞剂和血管紧张素转换酶抑制剂或血管紧张素Ⅱ受体拮抗剂的使用率却较2006年有所下降。

研究者分别于2006年在全国31个省、自治区和直辖市65家医院(中国冠心病二级预防架桥工程I期研究)和2012 年在全国21个省、自治区和直辖市34家医院(中国冠心病二级预防架桥工程Ⅲ期研究)连续入选≥18岁的住院冠心病患者332例和3391例。排除因外伤入院并怀疑ACS者及已参加任何一项药物临床试验者。将其中调查资料完整的ACS患者纳入本研究,2次调查的有效病例数均为3124例。

来源:刘军, 赵冬, 刘静等.2006至2012年急性冠状动脉综合征住院患者诊疗状况的变化.中华心血管病杂志2014,42:957.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=16238, encodeId=886f1623809, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:00:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15490, encodeId=fffe1549083, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 14:00:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039682, encodeId=6848203968210, content=<a href='/topic/show?id=9e105219577' target=_blank style='color:#2F92EE;'>#急性冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52195, encryptionId=9e105219577, topicName=急性冠心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Sep 15 23:33:00 CST 2015, time=2015-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14725, encodeId=bc6e14e25d2, content=这个结果不可靠, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Mon Jan 26 18:19:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14702, encodeId=d71014e02a4, content=too young !, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:12:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14701, encodeId=571414e017d, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:10:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14699, encodeId=7a561469975, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 13:25:00 CST 2015, time=2015-01-26, status=1, ipAttribution=)]
    2015-02-17 chinayinhan

    已阅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=16238, encodeId=886f1623809, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:00:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15490, encodeId=fffe1549083, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 14:00:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039682, encodeId=6848203968210, content=<a href='/topic/show?id=9e105219577' target=_blank style='color:#2F92EE;'>#急性冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52195, encryptionId=9e105219577, topicName=急性冠心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Sep 15 23:33:00 CST 2015, time=2015-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14725, encodeId=bc6e14e25d2, content=这个结果不可靠, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Mon Jan 26 18:19:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14702, encodeId=d71014e02a4, content=too young !, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:12:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14701, encodeId=571414e017d, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:10:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14699, encodeId=7a561469975, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 13:25:00 CST 2015, time=2015-01-26, status=1, ipAttribution=)]
    2015-02-15 午夜星河

    明白

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=16238, encodeId=886f1623809, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:00:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15490, encodeId=fffe1549083, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 14:00:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039682, encodeId=6848203968210, content=<a href='/topic/show?id=9e105219577' target=_blank style='color:#2F92EE;'>#急性冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52195, encryptionId=9e105219577, topicName=急性冠心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Sep 15 23:33:00 CST 2015, time=2015-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14725, encodeId=bc6e14e25d2, content=这个结果不可靠, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Mon Jan 26 18:19:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14702, encodeId=d71014e02a4, content=too young !, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:12:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14701, encodeId=571414e017d, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:10:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14699, encodeId=7a561469975, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 13:25:00 CST 2015, time=2015-01-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=16238, encodeId=886f1623809, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:00:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15490, encodeId=fffe1549083, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 14:00:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039682, encodeId=6848203968210, content=<a href='/topic/show?id=9e105219577' target=_blank style='color:#2F92EE;'>#急性冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52195, encryptionId=9e105219577, topicName=急性冠心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Sep 15 23:33:00 CST 2015, time=2015-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14725, encodeId=bc6e14e25d2, content=这个结果不可靠, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Mon Jan 26 18:19:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14702, encodeId=d71014e02a4, content=too young !, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:12:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14701, encodeId=571414e017d, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:10:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14699, encodeId=7a561469975, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 13:25:00 CST 2015, time=2015-01-26, status=1, ipAttribution=)]
    2015-01-26 223.104.5.**

    这个结果不可靠

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=16238, encodeId=886f1623809, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:00:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15490, encodeId=fffe1549083, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 14:00:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039682, encodeId=6848203968210, content=<a href='/topic/show?id=9e105219577' target=_blank style='color:#2F92EE;'>#急性冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52195, encryptionId=9e105219577, topicName=急性冠心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Sep 15 23:33:00 CST 2015, time=2015-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14725, encodeId=bc6e14e25d2, content=这个结果不可靠, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Mon Jan 26 18:19:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14702, encodeId=d71014e02a4, content=too young !, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:12:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14701, encodeId=571414e017d, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:10:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14699, encodeId=7a561469975, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 13:25:00 CST 2015, time=2015-01-26, status=1, ipAttribution=)]
    2015-01-26 loveios

    too young !

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=16238, encodeId=886f1623809, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:00:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15490, encodeId=fffe1549083, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 14:00:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039682, encodeId=6848203968210, content=<a href='/topic/show?id=9e105219577' target=_blank style='color:#2F92EE;'>#急性冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52195, encryptionId=9e105219577, topicName=急性冠心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Sep 15 23:33:00 CST 2015, time=2015-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14725, encodeId=bc6e14e25d2, content=这个结果不可靠, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Mon Jan 26 18:19:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14702, encodeId=d71014e02a4, content=too young !, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:12:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14701, encodeId=571414e017d, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:10:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14699, encodeId=7a561469975, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 13:25:00 CST 2015, time=2015-01-26, status=1, ipAttribution=)]
    2015-01-26 loveios

    too young to single

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=16238, encodeId=886f1623809, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:00:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15490, encodeId=fffe1549083, content=明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Feb 15 14:00:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039682, encodeId=6848203968210, content=<a href='/topic/show?id=9e105219577' target=_blank style='color:#2F92EE;'>#急性冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52195, encryptionId=9e105219577, topicName=急性冠心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Sep 15 23:33:00 CST 2015, time=2015-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14725, encodeId=bc6e14e25d2, content=这个结果不可靠, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Mon Jan 26 18:19:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14702, encodeId=d71014e02a4, content=too young !, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:12:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14701, encodeId=571414e017d, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 14:10:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14699, encodeId=7a561469975, content=too young to single, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1aae1611537, createdName=loveios, createdTime=Mon Jan 26 13:25:00 CST 2015, time=2015-01-26, status=1, ipAttribution=)]
    2015-01-26 loveios

    too young to single

    0

相关资讯

ESC 2014:Darapladib并不能降低急性冠脉综合征的主要心血管事件(SOLID-TIMI 52研究)

Darapladib是一种口服的选择性、可逆性磷脂酶A2(Lp-PLA2)抑制剂。在ESC 2014年会上发布的SOLID-TIMI 52研究显示,在因急性冠脉综合征(ACS)事件住院的患者中,Darapladib未能减少心血管事件。而在今年3月份ACC 2014年会上公布的STABILITY研究显示,Darapladib用于稳定型冠心病患者未能达到主要研究终点——复合主要心血管不良事件(MA

ESC 2014:亚洲急性冠脉综合征(ACS)患者中抗栓治疗管理模式的长期随访(EPICOR-Asia研究)

EPICOR-Asia观察性研究是迄今为止关于抗栓策略和临床(缺血-出血)、经济学、生活质量的最大注册研究,将关注ACS患者的临床真实治疗情况及其预后,评估不同治疗模式在临床实践中的潜在风险与获益。研究将入选包括中国、韩国、印度在内的亚太区8个国家219个中心共13000余例ACS患者,其中包括8000名中国患者,评估不同治疗模式在实际临床实践中对患者预后的影响,同时也评估了其对于疾病经济负担和对

JACC Cardiovasc Interv:陈绍良等提出冠脉复杂分叉病变新标准

关于如何区分冠状动脉复杂分叉病变和简单分叉病变,此前没有任何标准。 近期,南京医科大学附属第一医院陈绍良教授等在《JACC:Cardiovascular Interventions》杂志上发表的一项名为DEFINITION的研究中指出,可以通过观察患者接受经皮冠状动脉介入术(PCI)并置入药物洗脱支架1年时主要不良心脏事件(包括心源性死亡、心肌梗死和靶血管重建)发生率的高低,来区分冠脉复

Atherosclerosis:ACS患者使用10mg阿托伐他汀足矣(CHILLAS研究)

中国急性冠脉综合征(ACS)患者需要使用大剂量他汀强化降脂吗?由于之前国人的研究很少,中国的指南都是拿着国外的研究“照猫画虎”。而湘雅二院赵水平教授牵头的急性冠脉综合征患者强化降脂干预研究(CHILLAS)结果的正式公布,可以说是“几家欢乐,几家愁”了。 在这项研究中,常规他汀治疗的定义是10 mg/d阿托伐他汀或其他等效他汀,强化他汀治疗的定义是20或40 mg/d阿托伐他汀或其他等效

ESC 2014:《心肌血运重建指南》中国专家评析

  高炜教授在ESC会场   韩江莉医生在ESC现场 2014年欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)联合发布的心肌血运重建指南基于近些年随机临床试验(RCT)的结果,特别是新一代药物洗脱支架(DES)展现出的临床获益,对2010年版指南进行了重要更新,内容不仅涵盖了稳定性冠心病、急性冠脉综合征心肌血运重建的总体策略,更详细推荐了合并心力衰竭和心源性休克、合并糖尿

访CSC-ESC 联合论坛主席霍勇教授

9 月2 日,在今年的ESC年会上,中华医学会心血管病学分会(CSC)再次与ESC合作设立中欧联合论坛,双方共6位专家就急性冠脉综合征(ACS)和高血压相关的3个论题进行了对话与讨论。其中,我国复旦大学附属中山医院葛均波院士、沈阳军区总医院韩雅玲院士和新疆维吾尔自治区人民医院李南方教授分别介绍了接受经皮冠状动脉介入治疗(PCI)的ACS患者的强化他汀负荷、CYP2C19 基因多态性对ACS患者

Baidu
map
Baidu
map
Baidu
map